Cite
HARVARD Citation
Arriola, E. et al. (2016). Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First‐Line Therapy for Extensive‐Stage SCLC. Journal of thoracic oncology. 11 (9), p. . [Online].